Pembrolizumab
KEYNOTE-715-06/ECHO-306-06
Phase 2 small_molecule completed
Quick answer
Pembrolizumab for Lung Cancer is a Phase 2 program (small_molecule) at Incyte with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Incyte
- Indication
- Lung Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed